China Touyun Tech Group stock analysis
Want to see HK:1332 full AI Analyst Report?
China Touyun Tech Group (1332) Stock Price & Analysis
1332 Stock Chart & Stats
- Day’s Range
- HKD 0.15 - HKD 0.16
- 52-Week Range
- HKD 0.08 - HKD 0.41
- Previous Close
- HKD 0.16
- Volume
- N/A
- Average Volume (3M)
- 712.90K
- Market Cap
- HKD 456.92M
- Enterprise Value
- HKD 1.03B
- Total Cash (Recent Filing)
- HKD 4.39M
- Total Debt (Recent Filing)
- HKD 482.12M
- Price to Earnings (P/E)
- 2.3
- Beta
- -0.19
- Next Earnings
- Apr 01, 2027 (Est.)
- EPS Estimate
- N/A
- Next Dividend Ex-Date
- N/A
- Dividend Yield
- N/A
Bulls Say, Bears Say
Bulls Say
Positive Net Income
The return to positive net income provides some evidence that the company can produce an accounting profit under current conditions. However, because the result appears driven by non-operating items rather than core operations, it is a limited and lower-quality positive that requires sustained operating improvement to become durable.
Narrower Free Cash Flow Loss
A narrower free cash flow deficit indicates that cash consumption improved year over year, which could modestly reduce near-term funding pressure if maintained. The benefit remains conditional because free cash flow is still negative, so the company has not yet demonstrated internally funded operations or durable cash generation.
Historical Equity Base
The earlier period of positive equity and more manageable leverage shows that the company has previously operated with a stronger capital structure. This history may provide evidence of some past balance-sheet capacity, although the subsequent deterioration means it does not offset the current solvency concerns.
Bears Say
Severe Revenue Contraction
Repeated revenue contraction signals weakening demand, reduced scale, or loss of commercial traction in the core business. A 42.9% decline in 2025 materially reduces the revenue base available to absorb fixed costs, making recovery in operating profitability more difficult and increasing execution risk over the coming quarters.
Persistent Operating Losses
Deeply negative EBIT and EBITDA show that the underlying business is not currently covering its operating cost base through normal activities. This weakens earnings quality, limits self-funded investment capacity, and makes the positive 2025 net income less reliable because it was attributed to non-operating items.
Solvency And Cash Pressure
Negative equity combined with large debt relative to the capital base indicates a highly stressed balance sheet and limited financial flexibility. Persistent negative operating and free cash flow further increase reliance on external funding or asset sales, raising refinancing, restructuring, and continuity risks.
China Touyun Tech Group News
Touyun Biotech Unit Forms Thermal Technology Joint R&D Centre with Tianfu Yongxing Lab
China Touyun Tech Group ( ($HK:1332) ) has provided an update. Touyun Biotech Group Limited’s subsidiary Ronghe Times (Guangdong) New Materials Technology has partnered with Tianfu Yongxing Laboratory to establish
1332 FAQ
What was China Touyun Tech Group’s price range in the past 12 months?
What is China Touyun Tech Group’s market cap?
When is China Touyun Tech Group’s upcoming earnings report date?
How were China Touyun Tech Group’s earnings last quarter?
Is China Touyun Tech Group overvalued?
Does China Touyun Tech Group pay dividends?
What is China Touyun Tech Group’s EPS estimate?
How many shares outstanding does China Touyun Tech Group have?
What happened to China Touyun Tech Group’s price movement after its last earnings report?
Which hedge fund is a major shareholder of China Touyun Tech Group?
What is the TipRanks Smart Score and how is it calculated?
China Touyun Tech Group Stock Smart Score
Company Description
China Touyun Tech Group
Touyun Biotech Group Limited functions as a diversified investment holding company, primarily focused on the global design, development, manufacturing, and sale of a wide array of packaging products. Its market presence extends across Hong Kong, the People's Republic of China, Europe, North and South America, and other international territories. The company's operations are divided into four main business segments. The QR Code Business provides comprehensive solutions, including QR codes for product packaging and advertising display services. The Packaging Products segment specializes in creating and selling items such as luxury watch and jewelry boxes, eyewear cases, various bags and pouches, and retail display units. The Treasury Investment segment is engaged in the investment and trading of securities, alongside offering financial services like money lending, placing and underwriting, securities brokerage, asset management, and margin financing. Additionally, the Chlamydomonas Reinhardtii Product Business segment focuses on cultivating and marketing Chlamydomonas reinhardtii micro-algae and associated products. Beyond these core activities, the group also offers business intelligence IT solutions, online advertising display, and corporate management services. Established in 1989 and headquartered in Wan Chai, Hong Kong, the company transitioned to its current name, Touyun Biotech Group Limited, in May 2021, having previously been known as China Touyun Tech Group Limited.
- Sector
- Consumercyclical
- Industry
- Packaging & Containers
- CEO
- Liang Wang
- Employees
- 302
- Website
- touyunbiotech.com.hk
- Address
- HK
China Touyun Tech Group (1332) Earnings & Revenues
Technical Analysis
Overall Consensus
| Indicator | Bullish | Neutral | Bearish |
|---|---|---|---|
| Overall Consensus | 13 | 3 | 6 |
| Technical Analysis | 2 | 3 | 5 |
| Moving Averages | 11 | 0 | 1 |








